LTA4H and contact dermatitis: Indiscriminately targeting LTA4H dual enzyme activities may account for the observed paradoxical effect of bufexamac on the treatment of contact dermatitis, although the potential effect of bufexamac on the LTB4 level and Pro–Gly–Pro degradation in patients warrant further clinical investigation.